NCT06816355View on ClinicalTrials.gov

Exogenous Sex Hormones and PONV

CompletedOBSERVATIONAL
Enrollment

7,348

Participants

Timeline

Start Date

February 4, 2025

Primary Completion Date

February 4, 2025

Study Completion Date

February 4, 2025

Conditions
Postoperative Nausea and VomitingSex HormoneTransgender
Interventions
PROCEDURE

Orchiectomy

CPT:54520

PROCEDURE

Hysterectomy

CPT:1013911

PROCEDURE

Augmentation mammoplasty

CPT:19325

Trial Locations (1)

92555

Riverside University Health System Medical Center, Moreno Valley

All Listed Sponsors
lead

Riverside University Health System Medical Center

OTHER

NCT06816355 - Exogenous Sex Hormones and PONV | Biotech Hunter | Biotech Hunter